EBS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Emergent Biosolutions Inc (EBS).


$518.00M Market Cap.

As of 03/04/2025 5:00 PM ET (MRY) • Disclaimer

EBS Market Cap. (MRY)


EBS Shares Outstanding (MRY)


EBS Assets (MRY)


Total Assets

$1.39B

Total Liabilities

$906.90M

Total Investments

$0

EBS Income (MRY)


Revenue

$1.04B

Net Income

-$190.60M

Operating Expense

$471.00M

EBS Cash Flow (MRY)


CF Operations

$58.70M

CF Investing

$125.20M

CF Financing

-$190.00M

EBS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

EBS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,389,700,000 (-23.78%)

$1,823,200,000 (-42.42%)

$3,166,600,000 (7.02%)

$2,959,000,000 (2.63%)

Assets Current

$598,700,000 (-11.89%)

$679,500,000 (-43.88%)

$1,210,700,000 (-4.83%)

$1,272,100,000 (6.37%)

Assets Non-Current

$791,000,000 (-30.84%)

$1,143,700,000 (-41.53%)

$1,955,900,000 (15.95%)

$1,686,900,000 (-0.02%)

Goodwill & Intangible Assets

$501,500,000 (-11.49%)

$566,600,000 (-40.17%)

$947,000,000 (14.17%)

$829,500,000 (-10.79%)

Shareholders Equity

$482,800,000 (-25.64%)

$649,300,000 (-53.05%)

$1,383,000,000 (-14.58%)

$1,619,000,000 (11.89%)

Property Plant & Equipment Net

$270,600,000 (-29.31%)

$382,800,000 (-53.18%)

$817,600,000 (2.19%)

$800,100,000 (24.22%)

Cash & Equivalents

$105,600,000 (-5.46%)

$111,700,000 (-82.62%)

$642,600,000 (11.50%)

$576,300,000 (-7.27%)

Accumulated Other Comprehensive Income

-$5,200,000 (8.77%)

-$5,700,000 (-283.87%)

$3,100,000 (119.25%)

-$16,100,000 (36.36%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$311,700,000 (-5.23%)

$328,900,000 (-6.51%)

$351,800,000 (0.29%)

$350,800,000 (14.27%)

Trade & Non-Trade Receivables

$154,500,000 (-19.11%)

$191,000,000 (20.58%)

$158,400,000 (-42.34%)

$274,700,000 (18.97%)

Trade & Non-Trade Payables

$60,900,000 (-45.72%)

$112,200,000 (8.41%)

$103,500,000 (-19.71%)

$128,900,000 (-5.29%)

Accumulated Retained Earnings (Deficit)

-$212,400,000 (-874.31%)

-$21,800,000 (-102.97%)

$734,000,000 (-23.37%)

$957,800,000 (31.77%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$41,700,000 (-11.65%)

$47,200,000 (-34.26%)

$71,800,000 (-24.34%)

$94,900,000 (78.38%)

Total Debt

$663,700,000 (-22.84%)

$860,200,000 (-38.81%)

$1,405,800,000 (67.16%)

$841,000,000 (-3.86%)

Debt Current

$0 (0%)

$413,700,000 (-56.78%)

$957,300,000 (2929.43%)

$31,600,000 (-6.51%)

Debt Non-Current

$663,700,000 (48.65%)

$446,500,000 (-0.45%)

$448,500,000 (-44.59%)

$809,400,000 (-3.76%)

Total Liabilities

$906,900,000 (-22.74%)

$1,173,900,000 (-34.18%)

$1,783,600,000 (33.10%)

$1,340,000,000 (-6.70%)

Liabilities Current

$162,400,000 (-75.07%)

$651,300,000 (-47.04%)

$1,229,900,000 (229.03%)

$373,800,000 (-2.78%)

Liabilities Non-Current

$744,500,000 (42.46%)

$522,600,000 (-5.62%)

$553,700,000 (-42.69%)

$966,200,000 (-8.13%)

EBS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,043,600,000 (-0.54%)

$1,049,300,000 (-6.39%)

$1,120,900,000 (-37.47%)

$1,792,700,000 (15.26%)

Cost of Revenue

$681,300,000 (-3.42%)

$705,400,000 (1.69%)

$693,700,000 (-8.42%)

$757,500,000 (44.56%)

Selling General & Administrative Expense

$308,000,000 (-16.40%)

$368,400,000 (8.26%)

$340,300,000 (-2.32%)

$348,400,000 (14.87%)

Research & Development Expense

$70,700,000 (-36.54%)

$111,400,000 (-42.28%)

$193,000,000 (-17.52%)

$234,000,000 (-0.21%)

Operating Expenses

$471,000,000 (-55.99%)

$1,070,300,000 (78.41%)

$599,900,000 (-12.12%)

$682,600,000 (14.22%)

Interest Expense

$71,000,000 (-19.23%)

$87,900,000 (135.66%)

$37,300,000 (8.12%)

$34,500,000 (10.22%)

Income Tax Expense

$47,700,000 (62.80%)

$29,300,000 (1295.24%)

$2,100,000 (-97.49%)

$83,500,000 (-18.22%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$190,600,000 (74.94%)

-$760,500,000 (-239.81%)

-$223,800,000 (-196.93%)

$230,900,000 (-24.32%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$190,600,000 (74.94%)

-$760,500,000 (-239.81%)

-$223,800,000 (-196.93%)

$230,900,000 (-24.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$190,600,000 (74.94%)

-$760,500,000 (-239.81%)

-$223,800,000 (-196.93%)

$230,900,000 (-24.32%)

Weighted Average Shares

$53,000,000 (3.52%)

$51,200,000 (2.20%)

$50,100,000 (-6.36%)

$53,500,000 (1.52%)

Weighted Average Shares Diluted

$53,000,000 (3.52%)

$51,200,000 (2.20%)

$50,100,000 (-7.39%)

$54,100,000 (0.56%)

Earning Before Interest & Taxes (EBIT)

-$71,900,000 (88.82%)

-$643,300,000 (-248.86%)

-$184,400,000 (-152.85%)

$348,900,000 (-20.43%)

Gross Profit

$362,300,000 (5.35%)

$343,900,000 (-19.50%)

$427,200,000 (-58.73%)

$1,035,200,000 (0.37%)

Operating Income

-$108,700,000 (85.04%)

-$726,400,000 (-320.61%)

-$172,700,000 (-148.98%)

$352,600,000 (-18.72%)

EBS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$125,200,000 (-41.03%)

$212,300,000 (155.68%)

-$381,300,000 (-69.47%)

-$225,000,000 (-49.01%)

Net Cash Flow from Financing

-$190,000,000 (64.53%)

-$535,700,000 (-211.33%)

$481,200,000 (441.28%)

-$141,000,000 (-302.88%)

Net Cash Flow from Operations

$58,700,000 (128.45%)

-$206,300,000 (-504.99%)

-$34,100,000 (-110.62%)

$321,100,000 (-40.09%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$6,100,000 (98.85%)

-$530,900,000 (-900.75%)

$66,300,000 (246.68%)

-$45,200,000 (-109.97%)

Net Cash Flow - Business Acquisitions and Disposals

$140,200,000 (-46.87%)

$263,900,000 (208.29%)

-$243,700,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$15,000,000 (70.93%)

-$51,600,000 (55.44%)

-$115,800,000 (48.53%)

-$225,000,000 (-59.57%)

Issuance (Repayment) of Debt Securities

-$213,000,000 (60.80%)

-$543,400,000 (-196.31%)

$564,200,000 (1671.59%)

-$35,900,000 (-165.87%)

Issuance (Purchase) of Equity Shares

$10,800,000 (5.88%)

$10,200,000 (113.23%)

-$77,100,000 (14.43%)

-$90,100,000 (-385.13%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

-$1,200,000 (-340.00%)

$500,000 (266.67%)

-$300,000 (70.00%)

Share Based Compensation

$18,000,000 (-22.08%)

$23,100,000 (-48.78%)

$45,100,000 (6.37%)

$42,400,000 (-16.86%)

Depreciation Amortization & Accretion

$108,800,000 (-13.03%)

$125,100,000 (-12.70%)

$143,300,000 (15.75%)

$123,800,000 (8.12%)

EBS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

34.70% (5.79%)

32.80% (-13.91%)

38.10% (-33.97%)

57.70% (-12.97%)

Profit Margin

-18.30% (74.76%)

-72.50% (-262.50%)

-20.00% (-255.04%)

12.90% (-34.18%)

EBITDA Margin

3.50% (107.09%)

-49.40% (-1235.14%)

-3.70% (-114.02%)

26.40% (-25.84%)

Return on Average Equity (ROAE)

-37.30% (57.03%)

-86.80% (-474.83%)

-15.10% (-201.34%)

14.90% (-39.18%)

Return on Average Assets (ROAA)

-12.30% (64.24%)

-34.40% (-346.75%)

-7.70% (-197.47%)

7.90% (-33.61%)

Return on Sales (ROS)

-6.90% (88.74%)

-61.30% (-271.52%)

-16.50% (-184.62%)

19.50% (-30.85%)

Return on Invested Capital (ROIC)

-5.60% (86.63%)

-41.90% (-381.61%)

-8.70% (-150.29%)

17.30% (-29.96%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.66 (-1539.51%)

-0.16 (93.87%)

-2.64 (-126.26%)

10.06 (-34.98%)

Price to Sales Ratio (P/S)

0.49 (315.38%)

0.12 (-77.84%)

0.53 (-59.29%)

1.3 (-57.28%)

Price to Book Ratio (P/B)

1.07 (458.85%)

0.19 (-54.93%)

0.43 (-70.50%)

1.44 (-56.00%)

Debt to Equity Ratio (D/E)

1.88 (3.87%)

1.81 (40.16%)

1.29 (55.80%)

0.83 (-16.62%)

Earnings Per Share (EPS)

-3.6 (75.76%)

-14.85 (-232.21%)

-4.47 (-203.47%)

4.32 (-25.39%)

Sales Per Share (SPS)

19.69 (-3.92%)

20.49 (-8.40%)

22.37 (-33.23%)

33.51 (13.53%)

Free Cash Flow Per Share (FCFPS)

0.82 (116.38%)

-5.04 (-68.35%)

-2.99 (-266.59%)

1.8 (-76.04%)

Book Value Per Share (BVPS)

9.11 (-28.17%)

12.68 (-54.06%)

27.61 (-8.78%)

30.26 (10.22%)

Tangible Assets Book Value Per Share (TABVPS)

16.76 (-31.72%)

24.54 (-44.60%)

44.3 (11.30%)

39.8 (7.39%)

Enterprise Value Over EBIT (EV/EBIT)

-14 (-1300.00%)

-1 (87.50%)

-8 (-200.00%)

8 (-33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

27.76 (1700.69%)

-1.73 (94.91%)

-34.1 (-679.03%)

5.89 (-37.53%)

Asset Turnover

0.68 (42.11%)

0.47 (22.74%)

0.39 (-37.18%)

0.62 (1.48%)

Current Ratio

3.69 (253.50%)

1.04 (6.00%)

0.98 (-71.08%)

3.4 (9.42%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$43,700,000 (116.94%)

-$257,900,000 (-72.05%)

-$149,900,000 (-255.98%)

$96,100,000 (-75.67%)

Enterprise Value (EV)

$1,024,200,818 (13.99%)

$898,522,555 (-35.89%)

$1,401,479,855 (-49.65%)

$2,783,527,924 (-46.60%)

Earnings Before Tax (EBT)

-$142,900,000 (80.46%)

-$731,200,000 (-229.82%)

-$221,700,000 (-170.52%)

$314,400,000 (-22.79%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$36,900,000 (107.12%)

-$518,200,000 (-1160.83%)

-$41,100,000 (-108.69%)

$472,700,000 (-14.52%)

Invested Capital

$1,283,900,000 (-5.16%)

$1,353,800,000 (-22.77%)

$1,752,900,000 (-13.24%)

$2,020,400,000 (10.88%)

Working Capital

$436,300,000 (1447.16%)

$28,200,000 (246.88%)

-$19,200,000 (-102.14%)

$898,300,000 (10.71%)

Tangible Asset Value

$888,200,000 (-29.32%)

$1,256,600,000 (-43.39%)

$2,219,600,000 (4.23%)

$2,129,500,000 (9.02%)

Market Capitalization

$518,000,818 (315.99%)

$124,522,555 (-78.87%)

$589,179,855 (-74.81%)

$2,338,627,924 (-50.75%)

Average Equity

$510,350,000 (-41.76%)

$876,350,000 (-40.80%)

$1,480,200,000 (-4.63%)

$1,552,050,000 (24.86%)

Average Assets

$1,546,150,000 (-30.08%)

$2,211,225,000 (-23.69%)

$2,897,725,000 (-0.44%)

$2,910,450,000 (13.64%)

Invested Capital Average

$1,280,250,000 (-16.58%)

$1,534,625,000 (-27.74%)

$2,123,650,000 (5.49%)

$2,013,150,000 (13.50%)

Shares

54,184,186 (4.43%)

51,884,398 (4.00%)

49,888,218 (-7.27%)

53,798,664 (1.51%)